Oric Pharmaceuticals stock trades down to 10.69 as oricpharma promotes BTIG conference meeting

Traders Union
All News
Business & Wealth
Companies
Oric Pharmaceuticals down 0.42% today

Highlights

ORIC maintains a bullish technical structure above key moving averages, with immediate support at 10.32 and resistance at 10.81.
Momentum indicators signal strong buyer presence but suggest limited upside as oversold readings and weekly declines indicate possible near-term consolidation.
ORIC is expected to trade sideways between 10.30 and 11.30 next week, with less than 20% probability of a breakout.

Oric Pharmaceuticals invited participants of the conference to connect during the event. Details about the meetings are available through the company’s posted link.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish bias as price holds above key moving averages and Ichimoku support

ORIC is holding above its MA-20 ($10.32), MA-50 ($9.12), and MA-200 ($10.67), indicating a bullish undertone for short-, medium-, and long-term trends. The current price of $10.69 remains just above the Ichimoku Kijun on D1 ($9.76), providing immediate support, while near-term resistance emerges at MA-10 ($10.81) and key resistance aligns with MA-100 ($10.16) as support and MA-20 ($10.32) as near-term support.

Mixed momentum as strong buyer signals confront oversold conditions and consolidation

Momentum indicators on D1 show MACD firmly in Strong Buy territory and ADX at 27.24, signaling growing bullish momentum, but the oversold reading from Stoch RSI (2.24) and neutral CCI point to a potential pause or short-term pullback. BBP also reflects strong buyer dominance (0.41, Strong Buy forecast), despite the Awesome Oscillator being neutral overall. ORIC has slipped $0.04 (0.23%) from last week’s close at $10.73, with the current price toward the lower part of the weekly range, and weekly volatility stands at 9.90%. The week has seen moderate pressure but no dramatic directional change, as the price consolidates near recent lows following a steady decline from the high.

Sideways-to-downward risk as weekly signals skew bearish despite support range

Looking ahead, ORIC is expected to trade between $10.30 and $11.30 for the coming week, reflecting both historical weekly volatility and current market positioning. Based on W1 signals—where RSI and MAs are bullish but ADX is neutral and MACD is strongly bearish—the probability of a price increase next week is very low (less than 20%), making a downward or sideways move more likely. The baseline scenario is continued sideways movement between near-term support and resistance. In a bullish scenario, a break above $10.81 could open room toward $11.30. In a bearish scenario, a slip below $10.32 would bring focus to the $10.16–$9.76 region. This forecast range keeps ORIC above its 52-week low ($7.32) but well below its $14.93 high, highlighting that the stock remains in the lower half of its yearly range.

Previously it was reported that Oric Pharmaceuticals exhibited strong bullish momentum but faced caution due to increasingly overbought technical conditions. This article adds a new dimension by examining evolving market dynamics, with investors advised to monitor for decisive trend shifts that could signal a change in the prevailing outlook.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.